Andreas Ioannou
Andreas Ioannou is an expert in Cardiology at The Royal Free Hospital (United Kingdom). As of October 2026, ScienceLeadR ranks Andreas Ioannou in the top 1% of experts worldwide for Proteostasis Deficiencies. Andreas Ioannou has authored 207 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 786 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Biochemistry - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2015 - 2026
Number : 207
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Fully automated analysis of cardiotoxicity surveillance echocardiograms: a direct test-retest precision comparison with experts. PMID 42707651 — research design, intelligence, heart, neoplasms, cardiotoxicity, echocardiography, diagnosis, therapeutics, software, artificial intelligence | Eur Heart J Imaging Methods Pract | 2026 | 0 |
| Prevalence and Determinants of Asymmetric Septal Hypertrophy (ASH) in Diseases of Left Ventricular Hypertrophy (LVH). PMID 42544038 — hypertrophy, left ventricular, hypertrophy, cardiomyopathy, hypertrophic, amyloidosis, prevalence, sex, demography | Eur Heart J Cardiovasc Imaging | 2026 | 0 |
| Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders - The EXCALIBUR study. PMID 42201646 — arrhythmias, cardiac, phenotype, cardiology, amyloidosis, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy | J Am Coll Cardiol | 2026 | 0 |
| Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence. PMID 41674454 — research design, intelligence, phenotype, diagnostic imaging, amyloidosis, deep learning, echocardiography, diagnosis, learning, artificial intelligence | Circ Cardiovasc Imaging | 2026 | 0 |
| Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis. PMID 41098006 — intelligence, mortality, heart failure, disease progression, prealbumin, amyloidosis, echocardiography, artificial intelligence, transthyretin amyloid cardiomyopathy, transthyretin cardiac amyloidosis | Eur J Heart Fail | 2025 | 9 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map